- Home
- THAR vs LIFW Comparison
THAR vs LIFW Comparison
Compare THAR & LIFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- LIFW
- Stock Information
- Founded
- THAR 2017
- LIFW 2014
- Country
- THAR United States
- LIFW United States
- Employees
- THAR N/A
- LIFW N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- LIFW Computer Software: Prepackaged Software
- Sector
- THAR Health Care
- LIFW Technology
- Exchange
- THAR Nasdaq
- LIFW Nasdaq
- Market Cap
- THAR 2.8M
- LIFW 2.8M
- IPO Year
- THAR 2022
- LIFW N/A
- Fundamental
- Price
- THAR $2.17
- LIFW $0.07
- Analyst Decision
- THAR
- LIFW
- Analyst Count
- THAR 0
- LIFW 0
- Target Price
- THAR N/A
- LIFW N/A
- AVG Volume (30 Days)
- THAR 3.3M
- LIFW 16.3M
- Earning Date
- THAR 11-07-2024
- LIFW 11-14-2024
- Dividend Yield
- THAR N/A
- LIFW N/A
- EPS Growth
- THAR N/A
- LIFW N/A
- EPS
- THAR N/A
- LIFW N/A
- Revenue
- THAR N/A
- LIFW $10,734,000.00
- Revenue This Year
- THAR N/A
- LIFW $293,208.70
- Revenue Next Year
- THAR N/A
- LIFW N/A
- P/E Ratio
- THAR N/A
- LIFW N/A
- Revenue Growth
- THAR N/A
- LIFW 217.86
- 52 Week Low
- THAR $1.84
- LIFW $0.06
- 52 Week High
- THAR $79.50
- LIFW $7.10
- Technical
- Relative Strength Index (RSI)
- THAR 44.85
- LIFW 27.68
- Support Level
- THAR $1.90
- LIFW $0.08
- Resistance Level
- THAR $2.33
- LIFW $0.20
- Average True Range (ATR)
- THAR 0.54
- LIFW 0.03
- MACD
- THAR -0.04
- LIFW -0.00
- Stochastic Oscillator
- THAR 6.22
- LIFW 8.49
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About LIFW MSP Recovery Inc.
MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.